Menopause

Effects of isoflavones on BMD in postmenopausal women

June 26, 2020

Isoflavones significantly improve bone mineral density (BMD) and are safe in postmenopausal women, according to a systematic review and meta-analysis of 63 randomized controlled trials involving 6,427 postmenopausal women.

Can a healthier diet reduce menopause symptoms?

June 22, 2020

New research indicates that women may be able to reduce menopausal symptoms by increasing their intake of fruits and vegetables (FV).

Life lessons learned from post-menopausal hormone therapy

June 19, 2020

The overview underscores the importance of considering a woman’s age and time since menopause.

NAMS 31st Annual Meeting: September 30 to October 3

May 29, 2020

The North American Menopause Society (NAMS) will hold its 31st Annual Meeting at the Gaylord Rockies Hotel in Denver from Sept. 30 to Oct. 3, 2020.

Vasomotor symptoms and faster epigenetic aging

May 21, 2020

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms (VMS) on enrollment in the Women’s Health Initiative Observational Study (WHI-OS), or late-occurring VMS (at enrollment but not at/during their reported menopause transition, according to a study in The Journal of Clinical Endocrinology & Metabolism.

Impact of vulvovaginal atrophy on sexual function in postmenopausal women

May 13, 2020

For postmenopausal women with at least one vulvovaginal atrophy (VVA) symptom, the presence of physician-confirmed VVA is linked to significant impaired sexual function, according to a study from the European Vulvovaginal Epidemiological Survey (EVES).

Social inequalities impose negative impact in postmenopausal women with metabolic syndrome and osteoporosis

May 12, 2020

Social inequalities profoundly impact South Korean postmenopausal women who have metabolic syndrome and osteoporosis, according to a cross-sectional study in the journal Menopause.

Lessons learned from postmenopausal hormone therapy

May 12, 2020

The timing of postmenopausal hormone therapy (HT) significantly impacts coronary risk and overall benefit-to-risk profile, according to an overview of Women’s Health Initiative (WHI) results in the journal Menopause.

Impact of vulvovaginal atrophy on sexual function in postmenopausal women

April 09, 2020

New research indicates having at least one symptom of vulvovaginal atrophy is linked to significant impaired sexual function for postmenopausal women.

Vasomotor symptoms and faster epigenetic aging

March 24, 2020

Accelerated biological aging was seen in women who had severe menopausal vasomotor symptoms but not during their reported menopause transition, according to new research.